Blood

1. NAM S, Tetteh DN, Kappil EM, Mauk ED, et al
   Leukemia-associated myeloid cells support distinct T-ALL subtypes via unique signals converging on metabolic alterations.
   Blood. 2026 Oct 1:blood.2026033335. doi: 10.1182/blood.2026033335.
   

   >> Share

   
   
2. MANIACI BN, Porter JE, Carlson HL, Potter G, et al
   CSF3R compound mutations produce a hyperproliferative leukemia driven by overexpression of PIM kinases.
   Blood. 2026 Sep 9:blood.2026034085. doi: 10.1182/blood.2026034085.
   

   >> Share

   
   
3. OZYERLI-GOKNAR E, Nizamuddin S, Fetsch V, Biniossek ML, et al
   Menin-MLL inhibitors enhance JUND activity in MLLr leukemic cells, contributing to tumorigenesis and therapy resistance.
   Blood. 2026;148:1833-1847.
   

   >> Share

   
   

   
   BMC Cancer

4. HU Z, Tang X, Chen F, Li T, et al
   Clinical profiling of AML1::ETO and KIT exon 17 mutation in pediatric AML by high-throughput drug sensitivity.
   BMC Cancer. 2026;26:1159.
   

   >> Share

   
   

   
   Bone Marrow Transplant

5. CAMARILLAS S, Alonso-Saladrigues A, Navarro V, Marsal J, et al
   Consolidative allogeneic HCT vs. a watch-and-wait approach for B-cell acute lymphoblastic leukemia patients with early loss of B-cell aplasia after CAR T-cell therapy.
   Bone Marrow Transplant. 2026 Sep 29. doi: 10.1038/s41409-026-03057.
   

   >> Share

   
   

   
   Cancer Res

6. XIANG X, Luo B, Zhao L, Sui J, et al
   Targeting ClpP Rewires the Metabolic-Immune Axis in Acute Myeloid Leukemia.
   Cancer Res. 2026 Sep 28. doi: 10.1158/0008-5472.CAN-26-0477.
   

   >> Share

   
   

   
   Int J Hematol

7. LEI Y, Khawandanah M, Faisal M, Gong Z, et al
   Current management of central nervous system involvement in chronic lymphocytic leukemia/small lymphocytic lymphoma.
   Int J Hematol. 2026 Sep 28. doi: 10.1007/s12185-026-04283.
   

   >> Share

   
   

   
   J Pediatr Hematol Oncol

8. COLLAZO-ROMAN M, O'Connor J, Wilson WS, Smitherman A, et al
   Disseminated Ganciclovir-Resistant Cytomegalovirus in a Nontransplant Pediatric ALL Patient: A Case Report.
   J Pediatr Hematol Oncol. 2026;48:e285-e288.
   

   >> Share

   
   
9. LAZAROWITZ R, Picado J, Stankova J
   Catatonia in a 13-Year-Old With T-Cell Lymphoblastic Lymphoma Following Intrathecal Methotrexate.
   J Pediatr Hematol Oncol. 2026;48:361-363.
   

   >> Share

   
   
10. SAEED W, Rao ZUA
    Comment on: Assessment of Immunization Status Following Non-HSCT Chemotherapy-Treated Pediatric Leukemia Survivors-Toward Recovery-Guided Revaccination.
    J Pediatr Hematol Oncol. 2026 Sep 28. doi: 10.1097/MPH.0000000000003292.
    

    >> Share

    
    
11. REMME L, Watson D, Reimche P, Hoover A, et al
    Racial and Ethnic Disparities in Treatment Cost and Utilization in Pediatric and Young Adult Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2026;48:e332-e338.
    

    >> Share

    
    

    
    Leuk Lymphoma

12. ALHURAIJI A, Alshemmari S, Hamadah A, Jain N, et al
    Venetoclax consolidation deepens response and enables measurable residual disease-guided finite therapy in BTK inhibitor-treated chronic lymphocytic leukemia.
    Leuk Lymphoma. 2026 Oct 1:1-6. doi: 10.1080/10428194.2026.2741763.
    

    >> Share

    
    
13. LIN RY, Tinajero J, Gu Z, Agrawal V, et al
    Clinical outcomes of adults with PAX5-mutated or rearranged B-cell acute lymphoblastic leukemia.
    Leuk Lymphoma. 2026 Oct 1:1-8. doi: 10.1080/10428194.2026.2740988.
    

    >> Share

    
    
14. POKHARIYAL S, Chakraborty S, Arora S, Pal Singh P, et al
    Efficacy and safety of three-drug induction-based MASPORE 2003 chemotherapy protocol in standard- and intermediate-risk pediatric acute lymphoblastic leukemia: a decade-long single-center experience from India.
    Leuk Lymphoma. 2026 Oct 1:1-13. doi: 10.1080/10428194.2026.2739354.
    

    >> Share

    
    

    
    Leuk Res

15. COMBARIZA-VALLEJO JF, Diaz-Correa LM
    Comparison allogeneic hematopoietic stem cell transplantation and chemotherapy for consolidation in acute lymphoblastic leukemia in a Colombian Cohort. A propensity score matching analysis.
    Leuk Res. 2026;171:108330.
    

    >> Share

    
    

    
    Leukemia

16. STEINHAUSER S, Sreenivasan VKA, Baden D, Denker M, et al
    Alterations in 3D-DNA architecture drive unique leukemic profiles in IDH1- and DNMT3A-mutant acute myeloid leukemia.
    Leukemia. 2026 Oct 1. doi: 10.1038/s41375-026-03152.
    

    >> Share

    
    

    
    PLoS One

17. UEDA T, Fukushima K, Chi S, Haeno H, et al
    Genomic and clinical determinants of response to Azacitidine plus venetoclax in acute myeloid leukemia: Results from the HM-SCREEN-Japan 02 study.
    PLoS One. 2026;21:e0357898.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share